Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Monkhorst

Showing results (31-40 of 103) with videos related to

Pageof 11
Sort By:
Journal of Clinical Pathology|December 12, 2019
Multicentre study on the consistency of PD-L1 immunohistochemistry as predictive test for immunotherapy in non-small cell lung cancerRogier Butter, Nils A 't Hart, Gerrit K J Hooijer, et al.
Clinical Chemistry|April 12, 2021
An Automated Correction Algorithm (ALPACA) for ddPCR Data Using Adaptive Limit of Blank and Correction of False Positive Events Improves Specificity of Mutation DetectionDaan C L Vessies, Theodora C Linders, Mirthe Lanfermeijer, et al.
Cancer Cytopathology|October 27, 2020
Formalin fixation for optimal concordance of programmed death-ligand 1 immunostaining between cytologic and histologic specimens from patients with non-small cell lung cancerBregje M Koomen, Jose van der Starre-Gaal, Judith M Vonk, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2025
Improving the diagnosis of leptomeningeal metastases by molecular profiling of cell-free DNA from cerebrospinal fluidBerit M H van Linder, Dieta Brandsma, Els Verhoeven, et al.
Oncoimmunology|February 4, 2021
T cells expanded from renal cell carcinoma display tumor-specific CD137 expression but lack significant IFN-γ, TNF-α or IL-2 productionSaskia D van Asten, Rosa de Groot, Marleen M van Loenen, et al.
Molecular Oncology|November 27, 2023
Identification of protein biomarkers for prediction of response to platinum-based treatment regimens in patients with non-small cell lung cancerFranziska Böttger, Teodora Radonic, Idris Bahce, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 17, 2018
Programmed Death 1 Blockade With Nivolumab in Patients With Recurrent Malignant Pleural MesotheliomaJosine Quispel-Janssen, Vincent van der Noort, Jeltje F de Vries, et al.
Lung Cancer (Amsterdam, Netherlands)|June 25, 2026
Enrichment of SMARCA4 mutations in lung carcinomas presenting as cancer of unknown primaryTobias Martinot, Lydia H N Schonewille, Dina Ruano, et al.
The Oncologist|December 9, 2020
Phase I Study of Afatinib and Selumetinib in Patients with KRAS-Mutated Colorectal, Non-Small Cell Lung, and Pancreatic CancerEmilie M J van Brummelen, Sanne Huijberts, Carla van Herpen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2022
Tobacco Smoking-Related Mutational Signatures in Classifying Smoking-Associated and Nonsmoking-Associated NSCLCSophie M Ernst, Joanne M Mankor, Job van Riet, et al.
Pageof 11

Showing results (31-40 of 103) with videos related to

Sort By:
Pageof 11
Journal of Clinical Pathology|December 12, 2019
Multicentre study on the consistency of PD-L1 immunohistochemistry as predictive test for immunotherapy in non-small cell lung cancerRogier Butter, Nils A 't Hart, Gerrit K J Hooijer, et al.
Clinical Chemistry|April 12, 2021
An Automated Correction Algorithm (ALPACA) for ddPCR Data Using Adaptive Limit of Blank and Correction of False Positive Events Improves Specificity of Mutation DetectionDaan C L Vessies, Theodora C Linders, Mirthe Lanfermeijer, et al.
Cancer Cytopathology|October 27, 2020
Formalin fixation for optimal concordance of programmed death-ligand 1 immunostaining between cytologic and histologic specimens from patients with non-small cell lung cancerBregje M Koomen, Jose van der Starre-Gaal, Judith M Vonk, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2025
Improving the diagnosis of leptomeningeal metastases by molecular profiling of cell-free DNA from cerebrospinal fluidBerit M H van Linder, Dieta Brandsma, Els Verhoeven, et al.
Oncoimmunology|February 4, 2021
T cells expanded from renal cell carcinoma display tumor-specific CD137 expression but lack significant IFN-γ, TNF-α or IL-2 productionSaskia D van Asten, Rosa de Groot, Marleen M van Loenen, et al.
Molecular Oncology|November 27, 2023
Identification of protein biomarkers for prediction of response to platinum-based treatment regimens in patients with non-small cell lung cancerFranziska Böttger, Teodora Radonic, Idris Bahce, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 17, 2018
Programmed Death 1 Blockade With Nivolumab in Patients With Recurrent Malignant Pleural MesotheliomaJosine Quispel-Janssen, Vincent van der Noort, Jeltje F de Vries, et al.
Lung Cancer (Amsterdam, Netherlands)|June 25, 2026
Enrichment of SMARCA4 mutations in lung carcinomas presenting as cancer of unknown primaryTobias Martinot, Lydia H N Schonewille, Dina Ruano, et al.
The Oncologist|December 9, 2020
Phase I Study of Afatinib and Selumetinib in Patients with KRAS-Mutated Colorectal, Non-Small Cell Lung, and Pancreatic CancerEmilie M J van Brummelen, Sanne Huijberts, Carla van Herpen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2022
Tobacco Smoking-Related Mutational Signatures in Classifying Smoking-Associated and Nonsmoking-Associated NSCLCSophie M Ernst, Joanne M Mankor, Job van Riet, et al.
Pageof 11